DROGAS - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 28,769,675 | 29,844,176 | 24,644,895 | 23,382,069 | 34,983,830 | 43,619,435 | 48,635,828 | 52,429,073 |
| Profit before tax | 2,122,476 | 1,729,718 | 151,869 | 710,241 | 1,014,942 | 1,842,605 | 3,934,942 | 4,412,897 |
| Net profit | 1,799,185 | 1,463,916 | 118,461 | 597,891 | 849,354 | 1,595,705 | 3,362,288 | 3,544,864 |
| Equity | 3,348,485 | 3,012,401 | 3,130,862 | 3,728,753 | 4,578,107 | 6,173,812 | 9,536,100 | 13,080,964 |
| Liabilities | 4,043,741 | 4,801,359 | 4,642,570 | 5,669,843 | 5,551,880 | 6,868,557 | 6,084,164 | 8,522,074 |
| Non-current assets | 2,254,553 | 2,639,396 | 2,763,551 | 2,857,549 | 2,889,050 | 3,058,719 | 3,211,552 | 3,508,960 |
| Current assets | 5,601,547 | 5,790,410 | 5,640,813 | 7,187,369 | 8,753,022 | 12,352,960 | 14,754,836 | 19,013,222 |
| Total assets | 7,856,100 | 8,429,806 | 8,404,364 | 10,044,918 | 11,642,072 | 15,411,679 | 17,966,388 | 22,522,182 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 3,777,319 | 4,375,209 | 4,409,819 |
| Social insurance contributions | - | - | - | - | - | 1,396,018 | 1,565,175 | 1,753,465 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +3.3% | +3.7% | -17.4% | -5.1% | +49.6% | +24.7% | +11.5% | +7.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 22.9% | 17.4% | 1.4% | 6.0% | 7.3% | 10.4% | 18.7% | 15.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 53.7% | 48.6% | 3.8% | 16.0% | 18.6% | 25.8% | 35.3% | 27.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 6.3% | 4.9% | 0.5% | 2.6% | 2.4% | 3.7% | 6.9% | 6.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 7.4% | 5.8% | 0.6% | 3.0% | 2.9% | 4.2% | 8.1% | 8.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.2 | 1.6 | 1.5 | 1.5 | 1.2 | 1.1 | 0.6 | 0.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 59,136 | 59,868 | 51,875 | 54,451 | 77,713 | 93,889 | 105,291 | 110,727 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
DROGAS - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-05-16 | 2024-06-03 | 1201.58 |
| 2024-05-14 | 2024-05-14 | 47.36 |
DROGAS - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
DROGAS, UAB (code 211744970) is a Private Limited Liability Company engaged in retail sale of cosmetic and toilet articles. In 2025, revenue reached €52.43M, up 7.8% year on year and 20.2% over two years. Net profit increased to €3.54M from €3.36M in 2024 and €1.60M in 2023, while the profit margin remained broadly stable at 6.8% in 2025 after 6.9% in 2024 and 3.7% in 2023. The balance sheet also expanded: total assets rose to €22.52M in 2025 from €17.97M in 2024 and €15.41M in 2023. Equity strengthened to €13.08M, compared with liabilities of €8.52M, keeping the equity ratio at 58.1% and debt-to-equity at 0.65. Return on equity was 27.1% and return on assets 15.7% in 2025, supported by asset turnover of 2.33x. Revenue per employee was €110.8K and profit per employee €7.5K, indicating solid operating productivity.